Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats

Brain Research

Volumn 981, Issue 1-2, 2003, Pages 58-69

  Josko J ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Angiogenesis; BQ 123; Endothelin 1; Phosphoramidon; Subarachnoid hemorrhage; Vascular endothelial growth factor

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHORAMIDON; VASCULOTROPIN; ANTIHYPERTENSIVE AGENT; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIAL CELL GROWTH FACTOR; GLYCOPEPTIDE; LYMPHOKINE; PROTEINASE INHIBITOR; SIGNAL PEPTIDE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN STEM; CELL HYPOXIA; CEREBELLUM; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; HEMISPHERE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INJECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANK SUM TEST; RAT; STATISTICAL ANALYSIS; SUBARACHNOID HEMORRHAGE; VASOSPASM; ANIMAL; BRAIN CORTEX; CELL COUNT; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION; WISTAR RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CELL COUNT; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; GLYCOPEPTIDES; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDES, CYCLIC; PROTEASE INHIBITORS; RATS; RATS, WISTAR; SUBARACHNOID HEMORRHAGE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0141687001     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02920-2     Document Type: Article

References (59)

1. Adamis A.P., Miller J.W., Bernal M.T., D'Amico D.J., Folkman J., Yeo T.K., Yeo K.T. Increased vascular endothelial growth levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 118:1994;445-450.
2. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., Pasquale L.R., Thieme H., Iwamoto M.A., Park J.E., Nguyen H., Aiello L.M., Ferrara N., King G.L. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New Engl. J. Med. 331:1994;1480-1487.
3. Albayrak Z., Zhao Q., Sjesjo B.K., Smith M.L. Effect of transient focal ischemia on blood brain barrier permeability in the cat. Correlation to cell injury. Acta Neuropathol. 94:1997;158-163.
4. Armstead W.M. Influence of brain injury on vasopressin induced pial artery vasodilatation: role of superoxide anion. Am. J. Physiol. 270:1996;H 1272-H 1278.
5. Banai S., Jaklitsch M.T., Shou M., Lazarous P.F., Schweinowitz M., Biro S., Epstein S.E., Unger E.F. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 89:1994;2183-2189.
6. Bar T.H., Wolff J.R. On the vascularization of the rats cerebral cortex. 7th Eur. Conf. Microcirculation, Aberdeen (1972), Part I. Bibl. anat., No 11: 1973;515-519 Karger, Basel.
7. Bitzer M., Opitz H., Popp J., Morgalla M., Gruber A., Heiss E., Voigt K., Philippon J. Angiogenesis and brain oedema in intracranial meningiomas: Influence of vascular endothelial growth factor. Acta Neurochir. 140:1998;333-340.
8. Boutet M., Fuchs U., Gaehtgens P., Gauer O.H., Hammersen F., Heene D.L., Huttner I., Kirsch K., Lang J., Lash H.G., Lubbers D.W., Mason R.G., Poche R., Rona G., Schmid-Schonbein H., Sharp D.E. Handbuch der allgemeinen Pathologie. Microzirculation. 1997;Springer, Berlin, Heidelberg, New York.
9. Brogi E., Schatteman G., Wu T., Kim E.A., Vortikovski L., Kayt B., Isuer J.M. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Invest. 97:1996;469-476.
10. Chua C.C., Hamdy R.C., Chua B.H. Upregulation of endothelin-1 production by lysophosphatidic acid in rat aortic endothelial cells. Biochim. Biophys. Acta. 1405:1998;29-34.
11. Clozel M., Watanabe H. BQ-123, a peptidic endothelin receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci. 52:1993;825-834.
12. Dachs G.U., Chaplin D.J. Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 394:1998;485-490.
13. Detmar M., Brown L.F., Claffey K.P., Yeo K.T., Kocher O., Jackman R.W., Berse B., Dvorak H.F. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 180:1994;1141-1146.
14. Duvernoy H.M. Human Brainstem Vessels. 1978;Springer, Berlin, Heidelberg, New York.
15. Dvorak H.F., Brown L.F., Detmar M., Dvorak A.M. Vascular permeability factor/ vascular endothelial growth factor microvascular permeability and angiogenesis. Am. J. Pathol. 146:1995;1459-1472.
16. Ehreureich H., Anderson R.W., Fox C.H., Rieckmann P., Hoffman G.S., Traris W.D., Coligan J.E., Kehrl J.H., Fauci A.S. Endothelins peptides with potent vasoactive properties are produced by human macrophages. J. Exp. Med. 122:1990;1741-1748.
17. Ehrenreich H., Schilling L. New developments in the understanding of cerebral vasoregulation and vasospasm: the endothelin-nitric oxide network. Cleve. Clin. J. Med. 62:1995;105-116.
18. English D., Garcia J.G.N., Brindley D.N. Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc. Res. 49:2001;588-599.
19. Fava R.A., Olsen N.J., Spencer-Green G., Yeo K.T., Yeo T.K., Berse B., Jackman R.W., Senger D.R., Dvorak H.F., Brown L.F. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med. 180:1994;341-346.
20. Fischer S., Clauss M., Wiesnet M., Reuz D., Schaper W., Karliczek G.F. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am. J. Physiol. Cell Physiol. 276:1999;45-49.
21. Gulati A., Sen A.P., Sharma A.C. Role of endothelin and nitric oxide mechanisms in the resuscitative effects of diaspirin cross-link hemoglobin, a hemoglobin based blood substitute following hemorrhage in the rat. Am. J. Physiol. 273:1997;H 827-H 836.
22. Hashimoto E., Ogita T., Nakaoka T., Matsuoka R., Takao A., Kira Y. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am. J. Physiol. 267:1994;1948-1954.
23. Hayashi T., Abe K., Suzuki H., Itoyama Y. Rapid induction of VEGF gene expression after transient MCA occlusion in rat. Stroke. 28:1997;2039-2044.
24. Haynes W.G., Webb D.J. Contribution of endogenous degeneration of endothelin-1 to basal vascular tone. Lancet. 344:1994;852-854.
25. Ijichi A., Sakuma S., Tofilon P. Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures. Glia. 14:1995;87-93.
26. Issa R., Krupinski J., Bujny T., Kumar S., Kaluza J., Kumar P. Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lab. Invest. 79:2000;417-425.
27. Jośko J., Hendryk S., Jedrzejowska-Szypulka H., Slowiński J., Gwóźdź B., Lange D., Harabin-Slowińska M. Effect of endothelin-1 receptor antagonist BQ-123 on basilar artery diameter after subarachnoid hemorrhage (SAH) in rats. J. Physiol. Pharmacol. 2:2000;241-250.
28. Jośko J., Hendryk S., Jedrzejowska-Szypulka H., Gwóźdź B., Herman Z.S., Latka D., Kopeć N. Atrial natriuretic peptide secretion following subarachnoid hemorrhage in spontaneously hypertensive rats. J. Physiol. Pharmacol. 47:1996;641-648.
29. A receptor antagonist BQ-123 on changes of endothelin-1 level in plasma of rats with acute vasospasm following subarachnoid hemorrhage. J. Physiol. Pharmacol. 49:1998;367-375.
30. Jośko J., Hendryk S., Jedrzejowska-Szypulka H., Slowiński J., Gwóźdź B., Lange D., Harabin-Slowińska M. Reactivity of cerebral arteries after subarachnoid hemorrhage in rats administered phosphoramidon. Med. Sci. Monit. 6:2000;976-980.
31. Jośko J., Hendryk S., Jedrzejowska-Szypulka H., Slowiński J., Gwóźdź B., Lange D., Śnietura M., Żwirska-Korczala K., Jochem J. Cerebral angiogenesis after subarachnoid hemorrhage (SAH) and endothelin receptor blockage with BQ-123 antagonist in rats. J. Physiol. Pharmacol. 52:2001;237-248.
32. Jośko J., Hendryk S., Jedrzejowska-Szypulka H., Slowiński J., Gwóźdź B., Lange D., Śnietura M., Żwirska-Korczala K., Jochem J. Effect of phosphoramidon on brain tissue angiogenesis in the chronic phase of vasospasm after subarachnoid hemorrhage in the rat. Med. Sci. Monit. 6:2001;1182-1187.
33. Jośko J., Hendryk S., Jedrzejowska-Szypulka H., Slowiński J., Gwóźdź B., Jochem J. Expression of vascular endothelial growth factor (VEGF) in rat brain after subarachnoid hemorrhage and endothelin receptor blockage with BQ-123. Folia Neuropathol. 4:2001;243-251.
34. Kimelberg H.K. Current concepts of brain edema. Review of laboratory investigation. J. Neurosurg. 83:1995;1051-1059.
35. Pope R.M., Ferrara N. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol. 152:1994;4149-4156.
36. Ladoux A., Frelin C. Hypoxia as a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem. Biophys. Res. Commun. 1195:1993;1005-1010.
37. Lee M.E., de la Monte S.M., Bloch D.B., Quetarmous T. Expression of the potent vasoconstrictor endothelin in the human central nervous system. J. Clin. Invest. 86:1990;141-147.
38. Lee S.H., Wolf P.L., Escudero R., Deutsch R., Jamieson S.W., Thistlethwaite P.A. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. New Engl. J. Med. 9:2000;626-633.
39. MacCumber M.W., Ross C.A., Snyder S.H. Endothelin in the brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc. Natl. Acad. Sci. USA. 87:1990;2359-2363.
40. Macdonald R.L., Weir B.K.A. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 22:1991;971-982.
41. McLaren J., Prentice A., Charnock-Jones D.S., Smith S.K. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum. Reprod. 11:1996;220-223.
42. Maines M.D. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical application. FASEB J. 2:1988;2557-2568.
43. 1 as major regulator of vasculogenesis and angiogenesis. Cell. 72:1993;835-846.
44. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:1999;9-22.
45. Nishikawa R., Cheng S.Y., Nagashima R., Su Huang H.J., Cavenee W.K., Matsutani M. Expression of vascular endothelial growth factor in human brain tumors. Acta Neuropathol. 96:1998;453-462.
46. Okuda Y., Tsurumaru K., Suzuki S., Miyauchi T., Asano M., Hong Y., Sone H., Fujita R., Mizutani M., Kawakami Y., Nakajima T., Soma M., Matsuo K., Suzuki H., Yamashita K. Hypoxia and endothelin-1 induce VEGF production in human vascular smooth muscle cells. Life Sci. 63:1998;477-484.
47. Patt S., Sampaolo S., Theallier-Janko A., Tschairkin I., Cervos-Navarro J. Cerebral angiogenesis triggered by severe chronic hypoxia displays regional differences. J. Cereb. Blood Flow Metab. 17:1997;801-806.
48. Peters K.G., De Vries C., Williams L.T. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl. Acad. Sci. USA. 90:1993;8915-8919.
49. Plate K.H., Warnke P.C. Vascular endothelial growth factor. J. Neurooncol. 35:1997;365-372.
50. Pluta R.M., Bovel R.J., Afshar J.K., Clouse K., Bacic M., Ehrenreich H., Oldfield E.H. Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage. J. Neurosurg. 87:1997;287-293.
51. Sandstrom M., Johansson M., Sandstrom J., Bergenheim A.T., Henriksson R. Expression of the proteolytic factors, tPA and uPA, PAI-1 and VEGF during malignant glioma progression. Int. J. Dev. Neurosci. 17:1999;473-481.
52. Seifert V., Stolke D., Reale E. Ultrastructural changes of the basilar artery following experimental subarachnoid hemorrhage. Acta Neurochir. (Vien). 100:1989;164-171.
53. Shifren J.L., Tseng J.F., Zaloudek C.J., Ryan I.P., Meng Y.G., Ferrara N., Jaffe R.B., Taylor R.N. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab. 81:1996;3112-3118.
54. Sobey C.G., Faraci F.M. Subarachnoid haemorrhage: what happens to the cerebral arteries? Clin. Exp. Pharmacol. Physiol. 25:1998;867-876.
55. Solomon R.A., Antunes J.L., Chen R.Y., Bland L., Chien S. Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: a new animal model. Stroke. 16:1985;58-64.
56. Suzuki R., Masaoka H., Hirata Y., Marumo F., Isotani E., Hirakawa K. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J. Neurosurg. 77:1992;96-100.
57. Takeshita S., Zheng L.P., Brogi E., Kearney M., Pu L.Q., Bunting S., Ferrara N., Symes J.F., Isner J.M. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 93:1994;662-670.
58. van Bruggen N., Thibodeaux H., Palmer J.T., Lee W.P., Fu L., Carins B., Tumas D., Gerlai R., Wiliams S.P., van Lookeren-Campagne M., Ferrara N. VEGF antagonism reduces edema formation injury in the mouse brain. J. Clin. Ivest. 104:1999;1613-1620.
59. Zimmermann M., Seifert V. Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery. 43:1998;863-873.